<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kang J</submitter><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>e165369</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9977430</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(3)</volume><pubmed_abstract>Patients with nonalcoholic steatohepatitis (NASH) have increased expression of liver monocyte chemoattractant protein-1 (MCP-1), but its cellular source and contribution to various aspects of NASH pathophysiology remain debated. We demonstrated increased liver CCL2 (which encodes MCP-1) expression in patients with NASH, and commensurately, a 100-fold increase in hepatocyte Ccl2 expression in a mouse model of NASH, accompanied by increased liver monocyte-derived macrophage (MoMF) infiltrate and liver fibrosis. To test repercussions of increased hepatocyte-derived MCP-1, we generated hepatocyte-specific Ccl2-knockout mice, which showed reduced liver MoMF infiltrate as well as decreased liver fibrosis. Forced hepatocyte MCP-1 expression provoked the opposite phenotype in chow-fed wild-type mi</pubmed_abstract><journal>JCI insight</journal><pubmed_title>Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis.</pubmed_title><pmcid>PMC9977430</pmcid><funding_grant_id>R01 DK119767</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>P30 DK063608</funding_grant_id><funding_grant_id>R01 DK103818</funding_grant_id><funding_grant_id>DK103818,DK119767</funding_grant_id><funding_grant_id>R01 DK066525</funding_grant_id><pubmed_authors>Dongiovanni P</pubmed_authors><pubmed_authors>Valenti L</pubmed_authors><pubmed_authors>Kim K</pubmed_authors><pubmed_authors>Dapito DH</pubmed_authors><pubmed_authors>Mayfield B</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Zhu C</pubmed_authors><pubmed_authors>Creusot RJ</pubmed_authors><pubmed_authors>Pajvani UB</pubmed_authors><pubmed_authors>Bartolome A</pubmed_authors><pubmed_authors>Postigo-Fernandez J</pubmed_authors><pubmed_authors>Meroni M</pubmed_authors><pubmed_authors>Kang J</pubmed_authors><pubmed_authors>Ferrante AW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis.</name><description>Patients with nonalcoholic steatohepatitis (NASH) have increased expression of liver monocyte chemoattractant protein-1 (MCP-1), but its cellular source and contribution to various aspects of NASH pathophysiology remain debated. We demonstrated increased liver CCL2 (which encodes MCP-1) expression in patients with NASH, and commensurately, a 100-fold increase in hepatocyte Ccl2 expression in a mouse model of NASH, accompanied by increased liver monocyte-derived macrophage (MoMF) infiltrate and liver fibrosis. To test repercussions of increased hepatocyte-derived MCP-1, we generated hepatocyte-specific Ccl2-knockout mice, which showed reduced liver MoMF infiltrate as well as decreased liver fibrosis. Forced hepatocyte MCP-1 expression provoked the opposite phenotype in chow-fed wild-type mi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T20:09:37.953Z</modification><creation>2025-04-04T20:09:37.953Z</creation></dates><accession>S-EPMC9977430</accession><cross_references><pubmed>36752206</pubmed><doi>10.1172/jci.insight.165369</doi></cross_references></HashMap>